NYSE - Delayed Quote USD

Avanos Medical, Inc. (AVNS)

12.91
+0.29
+(2.30%)
At close: 4:00:02 PM EDT
12.91
0.00
(0.00%)
After hours: 4:05:02 PM EDT

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Sigfrido Delgado Senior Vice President of Operations 627.39k -- 1977
Ms. Mojirade James Senior VP, General Counsel & Corporate Secretary 738.22k -- 1967
Mr. Kerr W. Holbrook Senior VP & Chief Commercial Officer 798k -- 1967
Mr. David C. Pacitti M.B.A. Chief Executive Officer -- -- 1966
Mr. Jason M. Pickett Interim CFO, VP of Tax & Treasurer -- -- 1972
Ms. Siobhan Smyth VP & Chief Information Officer -- -- --
Mr. Jonathan Turner VP and Chief Ethics & Compliance Officer -- -- --
Ms. Katrine Kubis Vice President of Corporate Communications & Community Relations -- -- --
Mr. Scott Galovan Senior Vice President of Strategy & Corporate Development -- -- --
Mr. John W. Cato Vice President of Global Human Resources -- -- --

Avanos Medical, Inc.

5405 Windward Parkway
Suite 100 South
Alpharetta, GA 30004
United States
844 428 2667 https://avanos.com
Sector: 
Healthcare
Industry: 
Medical Devices
Full Time Employees: 
2,227

Description

Avanos Medical, Inc., a medical technology company, provides medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides non-opioid pain solutions, including surgical pain and recovery products, which comprise ON-Q and ambIT surgical pain pump, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which provide minimally invasive pain-relieving therapies, such as COOLIEF chronic pain products; OrthogenRx knee osteoarthritis hyaluronic acid pain relief injection products; and Trident radiofrequency ablation products to treat chronic pain conditions. The company markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.

Corporate Governance

Avanos Medical, Inc.’s ISS Governance QualityScore as of June 1, 2025 is 4. The pillar scores are Audit: 8; Board: 1; Shareholder Rights: 7; Compensation: 3.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

July 29, 2025 at 12:30 PM UTC - August 4, 2025 at 12:30 PM UTC

Avanos Medical, Inc. Earnings Date

Recent Events

June 2, 2025 at 12:00 AM UTC

SD: Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)

May 6, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

April 30, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

April 28, 2025 at 12:00 AM UTC

8-K/A: Corporate Changes & Voting Matters

April 25, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

April 18, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

March 17, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

March 14, 2025 at 12:00 AM UTC

DEF 14A: Proxy Statements

February 26, 2025 at 12:00 AM UTC

10-K: Periodic Financial Reports

January 13, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

Related Tickers